Job opening in Lambdagen Therapeutics

We are seeking an experienced Research Scientist to develop chimeric antigen receptor (CAR) Natural Killer cell-based cancer immunotherapies using proprietary lambda-integrase genome engineering technology. The ideal candidate will assist in the design of targeted iPSC-derived NK cell therapies, provide subject matter expertise for the development of allogeneic cell therapies targeting hematopoietic malignancies, and guide the evaluation of candidate cellular therapies from POC through pre-clinical studies.